These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12090585)
21. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Ordi J; Alejo M; Fusté V; Lloveras B; Del Pino M; Alonso I; Torné A Am J Surg Pathol; 2009 Nov; 33(11):1659-65. PubMed ID: 19730361 [TBL] [Abstract][Full Text] [Related]
22. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615 [TBL] [Abstract][Full Text] [Related]
23. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Lin MC; Mutter GL; Trivijisilp P; Boynton KA; Sun D; Crum CP Am J Pathol; 1998 May; 152(5):1313-8. PubMed ID: 9588899 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Rosenthal AN; Hopster D; Ryan A; Jacobs IJ Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510 [TBL] [Abstract][Full Text] [Related]
25. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases. Emanuels AG; Koudstaal J; Burger MP; Hollema H Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975 [TBL] [Abstract][Full Text] [Related]
26. DNA Methylation and p53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen Sclerosus. Voss FO; Berkhof J; Duin S; Fons G; van Beurden M; Steenbergen RDM; Bleeker MCG Mod Pathol; 2024 Sep; 37(9):100553. PubMed ID: 38925253 [TBL] [Abstract][Full Text] [Related]
27. p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma. Knopp S; Nesland JM; Tropé C; Holm R Am J Clin Pathol; 2006 Aug; 126(2):266-76. PubMed ID: 16891203 [TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases]. Bokhman JV; Maximov SJ; Ebert AD Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922 [TBL] [Abstract][Full Text] [Related]
29. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy. Kashofer K; Regauer S Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674 [TBL] [Abstract][Full Text] [Related]
30. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas. Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784 [TBL] [Abstract][Full Text] [Related]
31. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670 [TBL] [Abstract][Full Text] [Related]
32. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein. Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content. Ballouk F; Ambros RA; Malfetano JH; Ross JS Mod Pathol; 1993 May; 6(3):371-5. PubMed ID: 8346186 [TBL] [Abstract][Full Text] [Related]
34. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. van Seters M; ten Kate FJ; van Beurden M; Verheijen RH; Meijer CJ; Burger MP; Helmerhorst TJ J Clin Pathol; 2007 May; 60(5):504-9. PubMed ID: 16714399 [TBL] [Abstract][Full Text] [Related]
35. Role of TP53 mutations in vulvar carcinomas. Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386 [TBL] [Abstract][Full Text] [Related]
36. [The quantitative analysis of E6 HPV and P53 genes expression by QPCR (TaqMan) in the assessment of surgical treatment range in vulvar carcinoma induced by HTV infection]. Olejek A; Mazurek U; Kuśmierz D; Rzempołuch J; Wilczok T Ginekol Pol; 2001 Sep; 72(9):723-7. PubMed ID: 11757484 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Ansink AC; Krul MR; De Weger RA; Kleyne JA; Pijpers H; Van Tinteren H; De Kraker EW; Helmerhorst TJ; Heintz AP Gynecol Oncol; 1994 Feb; 52(2):180-4. PubMed ID: 8314136 [TBL] [Abstract][Full Text] [Related]
38. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279 [TBL] [Abstract][Full Text] [Related]
39. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Kruse AJ; Bottenberg MJ; Tosserams J; Slangen B; van Marion AM; van Trappen PO Int J Gynecol Pathol; 2008 Oct; 27(4):591-5. PubMed ID: 18753959 [TBL] [Abstract][Full Text] [Related]
40. Epithelial alterations adjacent to invasive squamous carcinoma of the vulva. Gómez Rueda N; García A; Vighi S; Belardi MG; Cardinal L; di Paola G J Reprod Med; 1994 Jul; 39(7):526-30. PubMed ID: 7966043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]